Complement C5 Inhibitor [EPC]

Complement C5 Inhibitor [EPC] was reported 121 times

Drugs of the Complement C5 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TYPE III IMMUNE COMPLEX MEDIATED REACTION 21 0.0376
1 BREAKTHROUGH HAEMOLYSIS 10 0.0251
2 EXTRAVASCULAR HAEMOLYSIS 6 0.0141
3 MENINGOCOCCAL BACTERAEMIA 1 0.0104
4 PANCREATIC ENZYME ABNORMALITY 1 0.0098
5 BILIRUBINURIA 1 0.0095
6 COMPLEMENT FACTOR ABNORMAL 1 0.0093
7 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
8 PURPURA FULMINANS 1 0.0039
9 MENINGOCOCCAL INFECTION 1 0.0032
10 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
11 HAEMOLYSIS 14 0.0018
12 INTRAVASCULAR HAEMOLYSIS 1 0.0018
13 ENTERITIS INFECTIOUS 3 0.0018
14 BILIARY TRACT INFECTION 1 0.0016
15 SERUM SICKNESS-LIKE REACTION 1 0.0016
16 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
17 CHOLANGITIS ACUTE 1 0.0013
18 CREATINE KINASE INCREASED 1 0.0013
19 VASCULITIC RASH 1 0.0013
20 KETONURIA 1 0.0012
21 OCULAR VASCULAR DISORDER 1 0.0012
22 HYPERLEUKOCYTOSIS 1 0.0011
23 PULPITIS DENTAL 1 0.0011
24 CARDIAC HYPERTROPHY 1 0.0009
25 HAEMOGLOBINURIA 1 0.0009
26 EMBOLISM ARTERIAL 1 0.0008
27 VASCULAR PURPURA 1 0.0007
28 PRERENAL FAILURE 1 0.0007
29 PANCREATIC ENZYMES INCREASED 1 0.0007
30 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
31 PNEUMONIA KLEBSIELLA 1 0.0005
32 SUDDEN HEARING LOSS 1 0.0005
33 HYPERURICAEMIA 2 0.0005
34 SPUTUM INCREASED 1 0.0005
35 HENOCH-SCHONLEIN PURPURA 1 0.0005
36 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
37 BILIRUBIN CONJUGATED INCREASED 1 0.0004
38 SYSTEMIC CANDIDA 1 0.0004
39 APLASTIC ANAEMIA 2 0.0004
40 BREAST SWELLING 1 0.0004
41 SERUM SICKNESS 1 0.0004
42 RETINAL VEIN OCCLUSION 1 0.0003
43 CHOLECYSTITIS 4 0.0003
44 BRAIN HERNIATION 1 0.0003
45 POLYMYALGIA RHEUMATICA 1 0.0003
46 BACTERIAL SEPSIS 1 0.0003
47 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
48 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
49 AMYLASE INCREASED 1 0.0003
50 POLYDIPSIA 1 0.0003
51 CARDIAC FAILURE CHRONIC 1 0.0002
52 ANURIA 2 0.0002
53 OCULAR ICTERUS 1 0.0002
54 HAEMOGLOBIN INCREASED 1 0.0002
55 HEPATIC FUNCTION ABNORMAL 8 0.0002
56 YELLOW SKIN 1 0.0002
57 PULSE ABSENT 1 0.0002
58 FULL BLOOD COUNT ABNORMAL 2 0.0002
59 NECROSIS 1 0.0002
60 CHOLECYSTITIS ACUTE 1 0.0002
61 ENTEROCOLITIS 1 0.0002
62 PLATELET COUNT ABNORMAL 1 0.0002
63 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
64 CHOLANGITIS 1 0.0002
65 PROCTALGIA 1 0.0002
66 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
67 JAUNDICE 4 0.0001
68 WRONG PRODUCT ADMINISTERED 1 0.0001
69 ACUTE HEPATIC FAILURE 2 0.0001
70 FURUNCLE 1 0.0001
71 BLOOD ALBUMIN DECREASED 1 0.0001
72 CIRCULATORY COLLAPSE 2 0.0001
73 PNEUMONIA BACTERIAL 1 0.0001
74 ANAEMIA 20 0.0001
75 TRANSFUSION 1 0.0001
76 BREAST PAIN 1 0.0001
77 SEPTIC SHOCK 4 0.0001
78 VASCULITIS 1 0.0001
79 BACTERAEMIA 1 0.0001
80 C-REACTIVE PROTEIN INCREASED 3 0.0001
81 CEREBRAL INFARCTION 2 0.0001
82 CYTOPENIA 1 0.0001
83 PLATELET COUNT INCREASED 1 0.0001
84 INFECTION 11 0.0001
85 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
86 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
87 SUBDURAL HAEMATOMA 1 0.0001
88 MYELODYSPLASTIC SYNDROME 1 0.0001
89 GASTROENTERITIS 1 0.0001
90 HAEMOGLOBIN DECREASED 7 0.0001
91 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
92 SEPSIS 7 0.0001
93 PYREXIA 21 0.0001
94 CELLULITIS 3 0.0001
95 RENAL IMPAIRMENT 5 0.0001
96 FLUID RETENTION 3 0.0001
97 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
98 DRUG ERUPTION 1 0.0001
99 ISCHAEMIC STROKE 1 0.0001
100 CEREBRAL HAEMORRHAGE 2 0.0001
101 BACTERIAL INFECTION 1 0.0001
102 CARDIAC FAILURE 4 0.0000
103 BONE MARROW FAILURE 1 0.0000
104 FAECES DISCOLOURED 1 0.0000
105 FEBRILE NEUTROPENIA 3 0.0000
106 BLOOD PRESSURE DECREASED 3 0.0000
107 SHOCK 1 0.0000
108 INTERSTITIAL LUNG DISEASE 2 0.0000
109 URINARY TRACT INFECTION 7 0.0000
110 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
111 COVID-19 7 0.0000
112 INFLAMMATION 2 0.0000
113 SKIN ULCER 1 0.0000
114 RESPIRATORY TRACT INFECTION 1 0.0000
115 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
116 LIVER FUNCTION TEST ABNORMAL 1 0.0000
117 MUSCULOSKELETAL STIFFNESS 3 0.0000
118 PLEURAL EFFUSION 2 0.0000
119 PNEUMONIA 10 0.0000
120 CHOLELITHIASIS 1 0.0000
121 URINARY RETENTION 1 0.0000
122 TYPE 2 DIABETES MELLITUS 1 0.0000
123 THROMBOCYTOPENIA 3 0.0000
124 ACUTE KIDNEY INJURY 4 0.0000
125 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
126 PSORIATIC ARTHROPATHY 1 0.0000
127 NEUTROPHIL COUNT DECREASED 1 0.0000
128 RHABDOMYOLYSIS 1 0.0000
129 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
130 LIVER DISORDER 1 0.0000
131 DEHYDRATION 3 0.0000
132 DRY SKIN 3 0.0000
133 THERAPY NON-RESPONDER 1 0.0000
134 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
135 RENAL DISORDER 1 0.0000
136 HYPOGLYCAEMIA 1 0.0000
137 LEUKOPENIA 1 0.0000
138 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
139 MEDICATION ERROR 1 0.0000
140 FLATULENCE 1 0.0000
141 SEIZURE 2 0.0000
142 OFF LABEL USE 15 0.0000
143 BONE PAIN 1 0.0000
144 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
145 NASOPHARYNGITIS 3 0.0000
146 INFUSION RELATED REACTION 1 0.0000
147 ARTHRALGIA 6 0.0000
148 CONSTIPATION 3 0.0000
149 CHRONIC KIDNEY DISEASE 1 0.0000
150 DRUG INTERACTION 2 0.0000
151 INFLUENZA LIKE ILLNESS 1 0.0000
152 URTICARIA 2 0.0000
153 NO ADVERSE EVENT 2 0.0000
154 PRURITUS 4 0.0000
155 ATRIAL FIBRILLATION 1 0.0000
156 HEADACHE 6 0.0000
157 HYPERTENSION 2 0.0000
158 PLATELET COUNT DECREASED 1 0.0000
159 MUSCULAR WEAKNESS 1 0.0000
160 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
161 PALPITATIONS 1 0.0000
162 DISEASE PROGRESSION 1 0.0000
163 EMOTIONAL DISTRESS 1 0.0000
164 OEDEMA PERIPHERAL 1 0.0000
165 NAUSEA 6 0.0000
166 INSOMNIA 2 0.0000
167 NEUTROPENIA 1 0.0000
168 RASH 3 0.0000
169 INJECTION SITE PAIN 2 0.0000
170 VOMITING 3 0.0000
171 FALL 2 0.0000
172 MYALGIA 1 0.0000
173 CHEST PAIN 1 0.0000
174 PAIN 3 0.0000
175 MALAISE 2 0.0000
176 DRUG INEFFECTIVE 6 0.0000
177 DECREASED APPETITE 1 0.0000
178 FEELING ABNORMAL 1 0.0000
179 FATIGUE 3 0.0000
180 PAIN IN EXTREMITY 1 0.0000
181 DIARRHOEA 2 0.0000
182 ASTHENIA 1 0.0000
183 DIZZINESS 1 0.0000
184 DYSPNOEA 1 0.0000